The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Therapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel
Abstract
Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis. We performed a prospective study comparing the efficacy of these drugs. Twenty-two patients were treated with praziquantel and 21 with albendazole. In addition, 16 patients were treated with symptomatic drugs only and used as controls. Treatment was discontinued in two patients receiving praziquantel and one patient receiving albendazole owing to acute decompensation of the increased intracranial pressure, and one of them died. Albendazole and praziquantel were effective when compared with the control group. However, albendazole was significantly more effective than praziquantel in reducing the total number of cysts in the computed tomographic scans (88% vs 50%). Despite these results, however, analysis of clinical course showed a high frequency of neurologic sequelae. Considering the risks and fallibility of anticysticercal therapy, the real solution for this serious disease continues to be prophylaxis of infestation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurocysticercosis: Short Course of Treatment With Albendazole
Alarcón, F. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520470099034 · Cited by 63
Cited by
García, H. H., Gonzalez, A. E., Evans, C. A., & Gilman, R. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14117-7 · Cited by 835
Current Consensus Guidelines for Treatment of Neurocysticercosis
García, H. H., Evans, C. A. W., Nash, T. E., Takayanagui, O. M., White, A. C., Botero, D., Rajshekhar, V., Tsang, V. C. W., Schantz, P. M., Allan, J. C., et al. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.747-756.2002 · Cited by 508
Self-citationUpdate on Eosinophilic Meningoencephalitis and Its Clinical Relevance
Graeff-Teixeira, C., da Silva, A. C. A., & Yoshimura, K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00044-08 · Cited by 287
Nanoformulations of Albendazole As Effective Anticancer and Antiparasite Agents
Movahedi, F., Li, L., Gu, W., & Xu, Z. P. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0102 · Cited by 34
Metadata
- Authors
- Takayanagui, O. M.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1992-03-01
- Volume
- 49
- Issue
- 3
- Pages
- 290
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2015302256
- Cited by
- 190
- References
- 1
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel. https://app.cochat.ai/papers/10.1001/archneur.1992.00530270106026
- The paper
- Takayanagui, O. M. (1992). Therapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel. Archives of Neurology. https://doi.org/10.1001/archneur.1992.00530270106026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
